Sales were down in both the Life Sciences and Clinical Diagnostics segments, but the firm reported an increase in net income compared to the year-ago period.
Posters described Droplet Digital PCR for oncology, somatic mosaicism detection, and gene editing methods development.
Spokespersons from Bio-Rad noted that there appears to be an increasing number of researchers using ddPCR for methylation analyses.
Sales for Bio-Rad's Life Science segment were flat, but increased 9 percent on a currency-neutral basis.
Bio-Rad scientist Jennifer Berman explains how ddPCR can help detect the basic efficiency of CRISPR/Cas9 and other genome editing technologies and more.
The researchers' proof-of-concept paper published in PLOS One demonstrated a method that could lead to more haplotype analysis in genomic studies of diseases.
The suit alleges Bio-Rad fired its former general counsel for pursuing an investigation into bribery committed by the company's employees and agents in China.
Both groups are making their detailed protocols available to researchers online.
Low-pass sequencing and digital PCR analysis of cell-free circulating tumor DNA could detect metastatic disease in primary breast cancer patients months before clinical diagnosis.
On a currency-neutral basis, quarterly revenues increased about 1 percent compared to the same quarter last year.
Researchers describe a way to share data while keeping it secure, Agence France Presse reports.
In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.
India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.
A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.